Items where authors include "Messenger, M"

Article

Frempong, SN orcid.org/0000-0002-3042-7393, Shinkins, B orcid.org/0000-0001-5350-1018, Howdon, D orcid.org/0000-0001-8052-2893 et al. (3 more authors) (2022) Early economic evaluation of an intervention to improve uptake of the NHS England Diabetes Prevention Programme (NDPP). Expert Review of Pharmacoeconomics and Outcomes Research, 22 (3). pp. 417-427. ISSN 1473-7167

Honey, S orcid.org/0000-0002-2675-7824, Neal, RD, Messenger, M orcid.org/0000-0002-4975-0158 et al. (1 more author) (2022) Acceptability and experience of a personalised proteomic risk intervention for type 2 diabetes in primary care: qualitative interview study with patients and healthcare providers. Primary Health Care Research & Development, 23. e24. ISSN 1463-4236

Savage, R, Messenger, M orcid.org/0000-0002-4975-0158, Neal, RD et al. (12 more authors) (2022) Development and validation of multivariable machine learning algorithms to predict risk of cancer in symptomatic patients referred urgently from primary care: a diagnostic accuracy study. BMJ Open, 12 (4). e053590. ISSN 2044-6055

Calanzani, N, Druce, PE, Snudden, C et al. (10 more authors) (2021) Identifying Novel Biomarkers Ready for Evaluation in Low-Prevalence Populations for the Early Detection of Upper Gastrointestinal Cancers: A Systematic Review. Advances in Therapy, 38 (2). pp. 3032-3065. ISSN 0741-238X

Stevenson, M, Metry, A and Messenger, M orcid.org/0000-0002-4975-0158 (2021) Modelling of hypothetical SARS-CoV-2 point of care tests for routine testing in residential care homes: rapid cost-effectiveness analysis. Health Technology Assessment, 25 (39). pp. 1-74. ISSN 1366-5278

Stevenson, M, Metry, A and Messenger, M orcid.org/0000-0002-4975-0158 (2021) Modelling of hypothetical SARS-CoV-2 point-of-care tests on admission to hospital from A&E: rapid cost-effectiveness analysis. Health Technology Assessment, 25 (21). pp. 1-68. ISSN 1366-5278

Graziadio, S, Urwin, SG, Cocco, P et al. (7 more authors) (2020) Unmet clinical needs for COVID-19 tests in UK health and social care settings. PLOS ONE, 15 (11). e0242125. ISSN 1932-6203

Crosbie, PAJ, Gabe, R, Simmonds, I et al. (20 more authors) (2020) Yorkshire Lung Screening Trial (YLST): protocol for a randomised controlled trial to evaluate invitation to community-based low-dose CT screening for lung cancer versus usual care in a targeted population at risk. BMJ Open, 10 (9). e037075. ISSN 2044-6055

Vasudev, NS orcid.org/0000-0001-8470-7481, Hutchinson, M, Trainor, S et al. (17 more authors) (2020) UK Multicenter Prospective Evaluation of the Leibovich Score in Localized Renal Cell Carcinoma: Performance has Altered Over Time. Urology, 136. pp. 162-168. ISSN 0090-4295

Snaith, B, Harris, MA, Shinkins, B orcid.org/0000-0001-5350-1018 et al. (4 more authors) (2019) Point of care creatinine testing in diagnostic imaging: A feasibility study within the outpatient computed tomography setting. European Journal of Radiology, 112. pp. 82-87. ISSN 0720-048X

Abignano, G, Blagojevic, J, Bissell, L-A orcid.org/0000-0002-2789-4652 et al. (16 more authors) (2019) European multicentre study validates enhanced liver fibrosis test as biomarker of fibrosis in systemic sclerosis. Rheumatology, 58 (2). key271. pp. 254-259. ISSN 1462-0324

Snaith, B, Harris, MA, Shinkins, B orcid.org/0000-0001-5350-1018 et al. (3 more authors) (2018) Point-of-care creatinine testing for kidney function measurement prior to contrast-enhanced diagnostic imaging: evaluation of the performance of three systems for clinical utility. Clinical Chemistry and Laboratory Medicine, 56 (8). pp. 1269-1276. ISSN 1434-6621

Smith, AF orcid.org/0000-0001-7709-1869, Messenger, M orcid.org/0000-0002-4975-0158, Hall, P et al. (1 more author) (2018) The Role of Measurement Uncertainty in Health Technology Assessments (HTAs) of In Vitro Tests. PharmacoEconomics, 36 (7). pp. 823-835. ISSN 1170-7690

Gopalakrishna, G, Langendam, M, Scholten, R et al. (470 more authors) (2017) Erratum to: Methods for evaluating medical tests and biomarkers. Diagnostic and Prognostic Research, 1 (11). pp. 2-5.

Cree, IA, Uttley, L, Buckley Woods, H et al. (10 more authors) (2017) The evidence base for circulating tumour DNA blood-based biomarkers for the early detection of cancer: a systematic mapping review. BMC Cancer, 17 (1). 697.

Gopalakrishna, G, Langendam, M, Scholten, R et al. (468 more authors) (2017) Erratum to: Methods for evaluating medical tests and biomarkers. Diagnostic and Prognostic Research, 1. 11. ISSN 2397-7523

Book Section

Seligmann, J, Messenger, M orcid.org/0000-0002-4975-0158, Seymour, M et al. (1 more author) (2017) Clinical Trials in Precision Oncology. In: Copson, ER, Hall, P, Board, RE, Cook, G and Selby, P, (eds.) Problem Solving Through Precision Oncology: A Case Study Based Reference and Learning Resource. Clinical Publishing , Abingdon, Oxon, UK . ISBN 978-1-84692-111-7

Messenger, M orcid.org/0000-0002-4975-0158, Hall, P, Shinkins, B et al. (3 more authors) (2017) Developing Diagnostic Tests for Precision Oncology. In: Copson, ER, Hall, P, Board, RE, Cook, G and Selby, P, (eds.) Problem Solving Through Precision Oncology A Case Study Based Reference and Learning Resource. Clinical Publishing , Abingdon, Oxon, UK , pp. 67-75. ISBN 978-1-84692-111-7

Monograph

Hall, PS, Mitchell, ED orcid.org/0000-0002-2833-1632, Smith, AF orcid.org/0000-0001-7709-1869 et al. (9 more authors) (2018) The future for diagnostic tests of acute kidney injury in critical care: evidence synthesis, care pathway analysis and research prioritisation. Report. NIHR Journals Library , Health Technology Assessment, Volume 22, Issue 32. ISSN 1366-5278

Proceedings Paper

Gopalakrishna, G, Langendam, M, Scholten, R et al. (468 more authors) (2017) Methods for Evaluating Medical Tests and Biomarkers. In: Diagnostic and Prognostic Research. Methods for evaluating medical tests and biomarkers: Symposium 2016, 19-20 Jul 2016, Birmingham, UK. BMC .